FDA Approved: MYHIBBIN — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MYHIBBIN (mycophenolate mofetil) submitted by Azurity Pharmaceuticals, Inc. The supplement pertains to changes to th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection
• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• MYHIBBIN (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYHIBBIN (MYCOPHENOLATE MOFETIL)